Showing 1 - 8 results of 8 for search 'Peng‐Peng Xu', query time: 0.04s
Refine Results
-
1
Microstructure and bonding properties of hot-rolled 7075/AZ31B clad sheets by Zong-he WU, Zi-chen QI, Peng-peng XU, Yun-peng ZHAO, Hong XIAO
Published 2020-05-01Get full text
Article -
2
Genetic subtype-guided immunochemotherapy in relapsed and refractory diffuse large B cell lymphoma: a phase 2 investigator-initiated nonrandomized clinical trial (GUIDANCE-06) by Yi-Ge Shen, Qing Shi, Wei Tang, Peng-Peng Xu, Yi-Wen Cao, Meng-Meng Ji, Zhong Zheng, Shu Cheng, Li Wang, Wei-Li Zhao
Published 2025-07-01Get full text
Article -
3
Characteristics and predictive model for diffuse large B-cell lymphoma with early chemoimmunotherapy failure by Ying-Yu Dong, Qing Shi, Wen Wu, Bing-Bing Zhao, Di Fu, Peng-Peng Xu, Shu Cheng, Guilhem Bousquet, Guilhem Bousquet, Guilhem Bousquet, Wei-Li Zhao, Wei-Li Zhao, Li Wang, Li Wang
Published 2025-06-01Get full text
Article -
4
Dual targeting PD-L1 and 4-1BB to overcome dendritic cell-mediated lenalidomide resistance in follicular lymphoma by Zhong Zheng, Jian-Biao Wang, Rui Sun, Nan Wang, Xiang-Qin Weng, Tian-Yuan Xu, Di Fu, Yan Feng, Peng-Peng Xu, Shu Cheng, Li Wang, Yan Zhao, Bin Qu, Chuan-Xin Huang, Wei-Li Zhao
Published 2025-01-01Get full text
Article -
5
An artificial intelligence model integrating culprit lesion diagnosis and risk assessment for acute coronary syndromeResearch in context by Peng Peng Xu, Bin Hu, Fan Zhou, Zhi Han Xu, Qian Chen, Tong Yuan Liu, Bang Jun Guo, Chang Sheng Zhou, Xin Wei Tao, Hong Yan Qiao, Jia Ni Zou, Xiang Ming Fang, Wen Cai Huang, Long Jiang Zhang
Published 2025-09-01Get full text
Article -
6
Response‐adapted zanubrutinib and tislelizumab as a potential strategy to enhance CD19 CAR T‐cell therapy in relapsed/refractory large B‐cell lymphoma: A retrospective observationa... by Rong Shen, Wei‐Guo Cao, Li Wang, Ling‐Shuang Sheng, Yi‐Lun Zhang, Wen Wu, Peng‐Peng Xu, Shu Cheng, Meng‐Ke Liu, Yan Dong, Yue Wang, Xiang‐Qin Weng, Xu‐Feng Jiang, Qi Song, Hong‐Mei Yi, Lei Li, Sheng Chen, Zi‐Xun Yan, Wei‐Li Zhao
Published 2025-04-01Get full text
Article -
7
Molecular heterogeneity of CD30+ peripheral T-cell lymphoma with prognostic significance and therapeutic implications: a retrospective multi-centre studyResearch in context by Yu-Jia Huo, Shu Cheng, Hong-Mei Yi, Ting Niu, Lei Fan, Guo-Hui Cui, Fu-Ling Zhou, Xian-Min Song, Fei Li, Ou Bai, Xiao-Jing Yan, Jun Shi, Ming-Ci Cai, Yao-Hui Huang, Lei Dong, Jie Xiong, Song Hu, Yu-Ran Qiu, Yan Zhao, Peng-Peng Xu, Li Wang, Min Lu, Hong-Mei Jing, Wei-Li Zhao
Published 2025-05-01Get full text
Article -
8
Extranodal diffuse large B‐cell lymphoma: Clinical and molecular insights with survival outcomes from the multicenter EXPECT study by Si‐Yuan Chen, Peng‐Peng Xu, Ru Feng, Guo‐Hui Cui, Li Wang, Shu Cheng, Rong‐Ji Mu, Hui‐Lai Zhang, Xiao‐Lei Wei, Yong‐Ping Song, Kai‐Yang Ding, Li‐Hua Dong, Zun‐Min Zhu, Shen‐Miao Yang, Xin Wang, Ting‐Bo Liu, Jian‐Da Hu, Xiao‐Yun Zheng, Ou Bai, Jing‐Yan Xu, Liang Huang, Wei Sang, Ke‐Qian Shi, Fan Zhou, Fei Li, Ai‐Bin Liang, Hui Zhou, Si‐Guo Hao, Hong‐Hui Huang, Bin Xu, Wen‐Bin Qian, Cai‐Xia Li, Zhi‐Ming Li, Chong‐Yang Wu, Xiao‐Bo Wang, Wen‐Yu Shi, Shu‐Ye Wang, Yu‐Yang Tian, Xi Zhang, Ke‐Shu Zhou, Li‐Juan Cui, Hui Liu, Huo Tan, Qing Leng, Dong‐Lu Zhao, Ting Niu, Wei‐Li Zhao
Published 2025-08-01Get full text
Article